Copyright
©The Author(s) 2021.
World J Gastroenterol. Dec 14, 2021; 27(46): 7995-8009
Published online Dec 14, 2021. doi: 10.3748/wjg.v27.i46.7995
Published online Dec 14, 2021. doi: 10.3748/wjg.v27.i46.7995
Total | With GI symptoms n = 163 | Without GI symptoms n = 438 | P value | |
Outcomes | ||||
ICU admission | 260 (43.55) | 78 (48.45) | 182 (41.74) | 0.143 |
ARDS | 206 (34.30) | 61 (38.12) | 145 (33.30) | 0.268 |
Shock | 130 (21.60) | 40 (25.00) | 90 (20.64) | 0.254 |
MOF | 48 (8.00) | 15 (9.32) | 33 (7.59) | 0.491 |
ALF | 7 (1.20) | 1 (0.62) | 6 (1.38) | 0.447 |
MV | 185 (30.80) | 55 (34.80) | 130 (29.90) | 0.252 |
ECMO | 4 (0.70) | 1 (0.62) | 3 (0.69) | 0.929 |
CRRT | 29 (4.80) | 6 (3.73) | 23 (5.28) | 0.610 |
Death | 34 (5.70) | 10 (6.21) | 24 (5.50) | 0.741 |
LOS (d) | 15 (8-21) | 15 (10-22) | 14 (7-21) | 0.036a |
Treatment | ||||
Azithromycin | 538 (90.12) | 151 (93.80) | 387 (88.80) | 0.068 |
HCQ | 540 (90.45) | 150 (93.20) | 390 (89.40) | 0.170 |
Chloroquine | 38 (6.30) | 7 (4.35) | 31 (7.11) | 0.388 |
Antibiotics | 493 (82.6) | 149 (92.6) | 344 (78.9) | < 0.001a |
Steroids | 248 (41.61) | 67 (41.60) | 181 (41.60) | 0.831 |
IFN | 62 (10.30) | 21 (13.04) | 41 (9.43) | 0.368 |
RBV | 91 (15.10) | 31 (19.25) | 60 (13.80) | 0.097 |
Tocilizumab | 236 (39.50) | 66 (40.99) | 170 (38.99) | 0.657 |
Lopinavir/ritonavir | 340 (56.6) | 96 (59.6) | 244 (56.0) | 0.422 |
Oseltamivir | 510 (85.43) | 139 (86.30) | 371 (85.09) | 0.702 |
Darunavir | 48 (8.0) | 14 (8.7) | 34 (7.8) | 0.782 |
Treatment groups | ||||
Group 1 | 524 (87.2) | 150 (92.0) | 374 (85.4) | 0.039a |
Group 2 | 431 (71.7) | 128 (78.5) | 303 (69.2) | 0.025a |
Group 3 | 307 (51.1) | 88 (54.0) | 219 (50.0) | 0.409 |
Group 4 | 181 (30.1) | 50 (30.7) | 131 (29.9) | 0.920 |
Group 5 | 61 (10.1) | 22 (13.5) | 39 (8.9) | 0.128 |
Group 6 | 56 (9.3) | 20 (12.3) | 36 (8.2) | 0.155 |
- Citation: Khan MU, Mushtaq K, Alsoub DH, Iqbal P, Ata F, Chaudhry HS, Iqbal F, Balaraju G, Maslamani MAA, Varughese B, Singh R, Ejji KA, Kaabi SA, Kamel YM, Butt AA. Digestive system involvement and clinical outcomes among COVID-19 patients: A retrospective cohort study from Qatar. World J Gastroenterol 2021; 27(46): 7995-8009
- URL: https://www.wjgnet.com/1007-9327/full/v27/i46/7995.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i46.7995